 The objective of this clinical investigation is to evaluate the long-term up to 12 months outcome of the 200 mm long self-expanding nitinol EverFlex ev3 stent in long femoropopliteal lesions TASC C D Is is the first time that the use of 200 mm long stents will be evaluated in these lesions. It is expected that the outcome of the treatment with this type of long stents will be better as the treatment of identical lesions lengths with multiple shorter stents. 